Cargando…
A single-cell mass cytometry platform to map the effects of preclinical drugs on cartilage homeostasis
No disease-modifying drug exists for osteoarthritis (OA). Despite success in animal models, candidate drugs continue to fail in clinical trials owing to the unmapped interpatient heterogeneity and disease complexity. We used a single-cell platform based on cytometry by time-of-flight (cyTOF) to prec...
Autores principales: | Sahu, Neety, Grandi, Fiorella Carla, Bhutani, Nidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744259/ https://www.ncbi.nlm.nih.gov/pubmed/36194485 http://dx.doi.org/10.1172/jci.insight.160702 |
Ejemplares similares
-
Single-cell mass cytometry reveals cross-talk between inflammation-dampening and inflammation-amplifying cells in osteoarthritic cartilage
por: Grandi, Fiorella Carla, et al.
Publicado: (2020) -
TET1 Directs Chondrogenic Differentiation by Regulating SOX9 Dependent Activation of Col2a1 and Acan In Vitro
por: Smeriglio, Piera, et al.
Publicado: (2020) -
High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry
por: Michelozzi, Ilaria M., et al.
Publicado: (2022) -
Soluble Collagen VI treatment enhances mesenchymal stem cells expansion for engineering cartilage
por: Smeriglio, Piera, et al.
Publicado: (2017) -
3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation
por: Smeriglio, Piera, et al.
Publicado: (2015)